Vaccine Approval Criteria definition

Vaccine Approval Criteria means that the Project COVID-19 Vaccine: (a) has received regular or emergency licensure or authorization from at least one of the Stringent Regulatory Authorities identified by WHO for vaccines procured and/or supplied under the COVAX Facility, as may be amended from time to time by WHO; (b) has received the WHO Prequalification or WHO Emergency Use Listing; or (c) has met such other criteria as may be agreed in writing between the Recipient and the Association.
Sample 1Sample 2Sample 3
Vaccine Approval Criteria means the requirement that Project COVID-19 Vaccine: (a) has received regular or emergency licensure or authorization from at least one (1) of the Stringent Regulatory Authority identified by WHO for vaccines procured and/or supplied under the COVAX Facility, as may be amended from time to time by WHO; or (b) has received WHO Prequalification (PQ) or WHO Emergency Use Listing (EUL); or (c) has met such other criteria as may be agreed in writing between the Recipient and the Association.
Sample 1Sample 2Sample 3
Vaccine Approval Criteria means that the vaccine: (a) has been approved by three (3) Stringent Regulatory Authorities (including by Emergency Use Authorization) in two (2) Regions; or (b) has received the WHO Emergency Use Listing and has been produced with a licensing or similar arrangement from a manufacturer of a parent/bioequivalent vaccine that has received a prior Stringent Regulatory Authority approval (including Emergency Use Authorization); or (c) has met such other criteria as may be agreed in writing between the Recipient and the Association.
Sample 1

Examples of Vaccine Approval Criteria in a sentence

  • All Project COVID-19 Vaccines shall satisfy the Vaccine Approval Criteria.

  • Given the unprecedented pace of vaccine development, and the need for both speed and prudence, COVID-19 vaccines financed under the proposed AF shall satisfy the World Bank’s Vaccine Approval Criteria.

  • The Project will support Vaccine Purchase including for the procurement of any vaccines that meet the WB Vaccine Approval Criteria and any ancillary goods needed to deploy the vaccines (e.g., syringes), if any.

  • All Project COVID-19 Vaccine shall satisfy the Vaccine Approval Criteria.

  • The information in the following table will be updated as more accurate information becomes available.*All vaccines deployed by the World Bank financed project will comply with the World Bank Vaccine Approval Criteria (VAC).

  • All Project COVID-19 Vaccines to be procured under the Project shall satisfy the Vaccine Approval Criteria.

  • There is uncertainty with vaccine purchase globally, but at this time, the Government will only use Bank financing for vaccines approved under the Bank’s Vaccine Approval Criteria or any modification that will result during project implementation.

  • The increased limit for retroactive financing will help the GoU recover costs already incurred for vaccines that meet the World Bank’s Vaccine Approval Criteria and procurement standards, and that have been or are scheduled to be deployed in accordance with the updated and approved Environmental and Social Management Framework (ESMF) for the AF2.

  • The purpose of the proposed restructuring is to help the Royal Government of Bhutan (RGOB) purchase and deploy safe and effective COVID-19 vaccines that meet the World Bank’s Vaccine Approval Criteria (VAC), strengthen relevant health systems that are necessary for a successful deployment, and to prepare for the future.The Project Development Objective (PDO) is to prevent, detect and respond to the threat posed by COVID-19 and to strengthen national systems for public health preparedness in Bhutan.

  • All Project COVID-19 Xxxxxxxx deployed under the Project shall satisfy the Vaccine Approval Criteria.


More Definitions of Vaccine Approval Criteria

Vaccine Approval Criteria means that the Project COVID-19 Vaccine: (a) has been approved by three (3) Stringent Regulatory Authorities (including by Emergency Use Authorization) in three (3) Regions; or (b) has received the WHO Prequalification and has been approved by one (1) Stringent Regulatory Authority (including by Emergency Use Authorization); or (c) has met such other criteria as may be agreed in writing between the Borrower and the Bank.
Sample 1
Vaccine Approval Criteria means that the Project COVID-19 Vaccine: (a) has received regular or emergency licensure or authorization from at least one of the Stringent
Sample 1

Related to Vaccine Approval Criteria

  • type-approval means the procedure whereby an approval authority certifies that a type of vehicle, system, component or separate technical unit satisfies the relevant administrative provisions and technical requirements;

  • ASAM criteria means admission, continued service, transfer, and discharge criteria for the treatment of substance use disorders as published by the American Society of Addiction Medicine (ASAM).

  • Approved clinical trial means a phase I, phase II, phase III, or phase IV clinical trial that is conducted in relation to the prevention, detection, or treatment of cancer or other life-threatening disease or Condition and is described in any of the following:

  • Phase I Clinical Trial means a human clinical trial that is intended to initially evaluate the safety and/or pharmacological effect of a Product in subjects or that would otherwise satisfy requirements of 21 C.F.R. 312.21(a), or its foreign equivalent.

  • Evaluation Criteria means the criteria set out under the clause 27 (Evaluation Process) of this Part C, which includes the Qualifying Criteria, Functional Criteria and Price and Preferential Points Assessment.

  • Phase III Clinical Trial means a human clinical trial of a product, the design of which is acknowledged by the FDA to be sufficient for such clinical trial to satisfy the requirements of 21 C.F.R. 312.21(c) (as amended or any replacement thereof), or a similar human clinical trial prescribed by the Regulatory Authority in a country other than the United States, the design of which is acknowledged by such Regulatory Authority to be sufficient for such clinical trial to satisfy the requirements of a pivotal efficacy and safety clinical trial.

  • Target Population means persons with low incomes who have one or more disabilities, including mental illness, HIV or AIDS, substance abuse, or other chronic health condition, or individuals eligible for services provided pursuant to the Lanterman Developmental Disabilities Services Act (Division 4.5 (commencing with Section 4500) of the Welfare and Institutions Code) and may include, among other populations, adults, emancipated minors, families with children, elderly persons, young adults aging out of the foster care system, individuals exiting from institutional settings, veterans, and homeless people.

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.

  • Indicators of student progress and growth means the results of assessment(s) of students as defined in N.J.A.C. 6A:8, Standards and Assessment.